Literature DB >> 22622369

Increased concentration of the CSF Tau protein and its phosphorylated form in the late juvenile metachromatic leukodystrophy form: a case report.

Joanna Tarasiuk1, Katarzyna Kapica-Topczewska, Alina Kułakowska, Dorota Halicka, Wiesław Drozdowski, Johannes Kornhuber, Piotr Lewczuk.   

Abstract

Metachromatic leukodystrophy (MLD) is an autosomal recessive, lysosomal storage disease due to deficiency or absence of arylsulfatase A enzyme (ASA) with sulfatide accumulation in the central and peripheral nervous system, kidneys, and gallbladder, leading to many dysfunctions. One of the clinical forms of the disease is a late juvenile MLD. To our best knowledge, this is the first report describing increased Tau/pTau and normal Aβ1-42 concentrations in the CSF of the late juvenile MLD patient.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22622369     DOI: 10.1007/s00702-012-0826-7

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  20 in total

Review 1.  Neurochemical dementia diagnostics in Alzheimer's disease: where are we now and where are we going?

Authors:  Piotr Lewczuk; Johannes Kornhuber
Journal:  Expert Rev Proteomics       Date:  2011-08       Impact factor: 3.940

2.  Probable metachromatic leukodystrophy/pseudodeficiency compound heterozygote at the arylsulfatase A locus with neurological and psychiatric symptomatology.

Authors:  C Hohenschutz; W Friedl; K H Schlör; A Waheed; E Conzelmann; K Sandhoff; P Propping
Journal:  Am J Med Genet       Date:  1988-09

3.  Molecular basis of different forms of metachromatic leukodystrophy.

Authors:  A Polten; A L Fluharty; C B Fluharty; J Kappler; K von Figura; V Gieselmann
Journal:  N Engl J Med       Date:  1991-01-03       Impact factor: 91.245

4.  Arylsulfatase A in the urine and metachromatic leukodystrophy.

Authors:  H Greene; G Hug; W K Schubert
Journal:  J Pediatr       Date:  1967-11       Impact factor: 4.406

5.  Results of the cord blood transplantation study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases.

Authors:  Paul L Martin; Shelly L Carter; Nancy A Kernan; Indira Sahdev; Donna Wall; Daniel Pietryga; John E Wagner; Joanne Kurtzberg
Journal:  Biol Blood Marrow Transplant       Date:  2006-02       Impact factor: 5.742

6.  Converging molecular pathways in human neural development and degeneration.

Authors:  Niklas Mattsson; Karin Sävman; Gustaf Osterlundh; Kaj Blennow; Henrik Zetterberg
Journal:  Neurosci Res       Date:  2009-12-02       Impact factor: 3.304

7.  Motor and psycho-cognitive clinical types in adult metachromatic leukodystrophy: genotype/phenotype relationships?

Authors:  Nicole Baumann; Jean-Claude Turpin; Mireille Lefevre; Benoit Colsch
Journal:  J Physiol Paris       Date:  2002 Apr-Jun

8.  Neurochemical dementia diagnostics: a simple algorithm for interpretation of the CSF biomarkers.

Authors:  Piotr Lewczuk; Rüdiger Zimmermann; Jens Wiltfang; Johannes Kornhuber
Journal:  J Neural Transm (Vienna)       Date:  2009-08-04       Impact factor: 3.575

9.  In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: correction of neuropathology and protection against learning impairments in affected mice.

Authors:  A Consiglio; A Quattrini; S Martino; J C Bensadoun; D Dolcetta; A Trojani; G Benaglia; S Marchesini; V Cestari; A Oliverio; C Bordignon; L Naldini
Journal:  Nat Med       Date:  2001-03       Impact factor: 53.440

10.  Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease: original data and review of the literature.

Authors:  Piotr Lewczuk; Hermann Esselmann; Mirko Bibl; Georg Beck; Juan Manuel Maler; Markus Otto; Johannes Kornhuber; Jens Wiltfang
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 2.866

View more
  4 in total

1.  The clinical features and diagnosis of Metachromatic leukodystrophy: A case series of Iranian Pediatric Patients.

Authors:  Sayena Jabbehdari; Elham Rahimian; Narjes Jafari; Sara Sanii; Simin Khayatzadehkakhki; Habibe Nejad Biglari
Journal:  Iran J Child Neurol       Date:  2015

Review 2.  APP Function and Lipids: A Bidirectional Link.

Authors:  Marcus O W Grimm; Janine Mett; Heike S Grimm; Tobias Hartmann
Journal:  Front Mol Neurosci       Date:  2017-03-10       Impact factor: 5.639

3.  Lipid Profiling of Alzheimer's Disease Brain Highlights Enrichment in Glycerol(phospho)lipid, and Sphingolipid Metabolism.

Authors:  Sumeyya Akyol; Zafer Ugur; Ali Yilmaz; Ilyas Ustun; Santosh Kapil Kumar Gorti; Kyungjoon Oh; Bernadette McGuinness; Peter Passmore; Patrick G Kehoe; Michael E Maddens; Brian D Green; Stewart F Graham
Journal:  Cells       Date:  2021-09-29       Impact factor: 6.600

Review 4.  The impact of cholesterol, DHA, and sphingolipids on Alzheimer's disease.

Authors:  Marcus O W Grimm; Valerie C Zimmer; Johannes Lehmann; Heike S Grimm; Tobias Hartmann
Journal:  Biomed Res Int       Date:  2014-02-19       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.